Melanoma inhibitory activity (MIA): An important molecule in melanoma development and progression

Pigment Cell Research

Volumn 18, Issue 6, 2005, Pages 411-416

  Bosserhoff, Anja Katrin ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Invasion; Malignant melanoma; Melanoma inhibitory activity; Metastasis; Serum marker; Transcriptional regulation

Indexed keywords

HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL LITERATURE; MELANOMA; MOLECULAR MODEL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; SKIN CARCINOMA;

ANIMALS; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MELANOMA; NEOPLASM PROTEINS; SKIN NEOPLASMS;

EID: 28044443875     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0749.2005.00274.x     Document Type: Review

References (34)

1. Apfel, R., Lottspeich, F., Hoppe, J., Behl, C., Durr, G., and Bogdahn, U. (1992). Purification and analysis of growth regulating proteins secreted by a human melanoma cell line. Melanoma Res. 2, 327-336.
2. Blesch, A., Bosserhoff, A.K., Apfel, R., Behl, C., Hessdoerfer, B., Schmitt, A., Jachimczak, P., Lottspeich, F., Buettner, R., and Bogdahn, U. (1994). Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res. 54, 5695-5701.
3. Bogdahn, U., Apfel, R., Hahn, M., Gerlach, M., Behl, C., Hoppe, J., and Martin, R. (1989). Autocrine tumor cell growth-inhibiting activities from human malignant melanoma. Cancer Res. 49, 5358-5363.
4. Bosserhoff, A.K., Hein, R., Bogdahn, U., and Buettner, R. (1996). Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA. J. Biol. Chem. 271, 490-495.
5. Bosserhoff, A.K., Moser, M., Hein, R., Landthaler, M., and Buettner, R. (1999). In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers. J. Pathol. 187, 446-454.
6. Bosserhoff, A.K., Echtenacher, B., Hein, R., and Buettner, R. (2001). Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo. Melanoma Res. 11, 417-421.
7. Bosserhoff, A.K., Moser, M., Scholmerich, J., Buettner, R., and Hellerbrand, C. (2003a). Specific expression and regulation of the new melanoma inhibitory activity-related gene MIA2 in hepatocytes. J. Biol. Chem. 278, 15225-15231.
8. Bosserhoff, A.K., Stoll, R., Sleeman, J.P., Bataille, F., Buettner, R., and Holak, T.A. (2003b). Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity. Lab. Invest. 83, 1583-1594.
9. Bosserhoff, A.K., Moser, M., and Buettner, R. (2004). Characterization and expression pattern of the novel MIA homolog TANGO. Gene Expr. Patterns. 4, 473-479.
10. Cohen-Salmon, M., Frenz, D., Liu, W., Verpy, E., Voegeling, S., and Petit, C. (2000). FDP, a new fibrocyte-derived protein related to MIA/CD-RAP, has an in vitro effect on the early differentiation of the inner ear mesenchyme. J. Biol. Chem. 275, 40036-40041.
11. Dupin, E., and Le Douarin, N.M. (2003). Development of melanocyte precursors from the vertebrate neural crest. Oncogene 22, 3016-3023.
12. Golob, M., Buettner, R., and Bosserhoff, A.K. (2000). Characterization of a transcription factor binding site, specifically activating MIA transcription in melanoma. J. Invest. Dermatol. 115, 42-47.
13. Grant, R.P., Spitzfaden, C., Altroff, H., Campbell, I.D., and Mardon, H.J. (1997). Structural requirements for biological activity of the ninth and tenth Fill domains of human fibronectin. J. Biol. Chem. 272, 6159-6166.
14. Guba, M., Bosserhoff, A.K., Steinbauer, M., Abels, C., Anthuber, M., Buettner, R., and Jauch, K.W. (2000). Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo. Br. J. Cancer 83, 1216-1222.
15. Haass, N.K., Smalley, K.S., Li, L., and Herlyn, M. (2005). Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res. 18, 150-159.
16. Hau, P., Wise, P., Bosserhoff, A.K., Blesch, A., Jachimczak, P., Tschertner, I., Bogdahn, U., and Apfel, R. (2002). Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIA/CD-RAP) [corrected]. J. Invest. Dermatol. 119, 562-569.
17. Hellerbrand, C., Bataille, F., Schlegel, J., Hartmann, A., Muhlbauer, M., Scholmerich, J., Buttner, R., Hofstadter, F., and Bosserhoff, A.K. (2005). In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers. Liver Int. 25, 357-366.
18. Jachimczak, P., Apfel, R., Bosserhoff, A.K., Fabel, K., Hau, P., Tschertner, I., Wise, P., Schlingensiepen, K.H., Schuler-Thurner, B., and Bogdahn, U. (2005). Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques. Int. J. Cancer 113, 88-92.
19. Larue, L., Kumasaka, M., and Goding, C.R. (2003). Beta-catenin in the melanocyte lineage. Pigment Cell Res. 16, 312-317.
20. Levy, C., Nechushtan, H., and Razin, E. (2002). A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor. J. Biol. Chem. 277, 1962-1966.
21. Lougheed, J.C., Domaille, P.J., and Handel, T.M. (2002). Solution structure and dynamics of melanoma inhibitory activity protein. J. Biomol. NMR 22, 211-223.
22. Perez, R.P., Zhang, P., Bosserhoff, A.K., Buettner, R., and Abu-Hadid, M. (2000). Expression of melanoma inhibitory activity in melanoma and nonmelanoma tissue specimens. Hum. Pathol. 31, 1381-1388.
23. Poser, I., and Bosserhoff, A.K. (2004). Transcription factors involved in development and progression of malignant melanoma. Histol. Histopathol. 19, 173-188.
24. Poser, I., Golob, M., Weidner, M., Buettner, R., and Bosserhoff, A.K. (2002). Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression. Cancer Res. 62, 5962-5966.
25. Poser, I., Golob, M., Buettner, R., and Bosserhoff, A.K. (2003). Up-regulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype. Mol. Cell Biol. 23, 2991-2998.
26. Poser, I., Tatzel, J., Kuphal, S., and Bosserhoff, A.K. (2004). Functional role of MIA in melanocytes and early development of melanoma. Oncogene 23, 6115-6124.
27. Rendtorff, N.D., Frodin, M., Attie-Bitach, T., Vekemans, M., and Tommerup, N. (2001). Identification and characterization of an inner ear-expressed human melanoma inhibitory activity (MIA)-like gene (MIAL) with a frequent polymorphism that abolishes translation. Genomics 71, 40-52.
28. Robertson, N.G., Heller, S., Lin, J.S., Resendes, B.L., Weremowicz, S., Denis, C.S., Bell, A.M., Hudspeth, A.J., and Morion, C.C. (2000). A novel conserved cochlear gene, OTOR: identification, expression analysis, and chromosomal mapping. Genomics 66, 242-248.
29. Stoll, R., Renner, C., Ambrosius, D., Golob, M., Voelter, W., Buettner, R., Bosserhoff, A.K., and Holak, T.A. (2000). Sequence-specific 1H, 13C, and 15N assignment of the human melanoma inhibitory activity (MIA) protein. J. Biomol. NMR 17, 87-88.
30. Stoll, R., Renner, C., Zweckstetter, M., Bruggert, M., Ambrosius, D., Palme, S., Engh, R.A., Golob, M., Breibach, I., Buettner, R. et al. (2001). The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold. EMBO J. 20, 340-349.
31. Stoll, R., Renner, C., Buettner, R., Voelter, W., Bosserhoff, A.K., and Holak, T.A. (2003). Backbone dynamics of the human MIA protein studied by (15)N NMR relaxation: implications for extended interactions of SH3 domains. Protein Sci. 12, 510-519.
32. Tatzel, J., Poser, I., Schroeder, J., and Bosserhoff, A.K. (2005). Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes. Pigment Cell Res. 18, 92-101.
33. Vance, K.W., and Goding, C.R. (2004). The transcription network regulating melanocyte development and melanoma. Pigment Cell Res. 17, 318-325.
34. Weilbach, F.X., Bogdahn, U., Pool, M., Apfel, R., Behl, C., Drenkard, D., Martin, R., and Hoehn, H. (1990). Melanoma-inhibiting activity inhibits cell proliferation by prolongation of the S-phase and arrest of cells in the G2 compartment. Cancer Res. 50, 6981-6986.